Bio-Rad Laboratories Company Profile (NYSE:BIO)

Analyst Ratings

Consensus Ratings for Bio-Rad Laboratories (NYSE:BIO) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $174.50 (20.27% upside)

Analysts' Ratings History for Bio-Rad Laboratories (NYSE:BIO)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Leerink SwannBoost Price Target$143.00 -> $149.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Bio-Rad Laboratories (NYSE:BIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1$0.60$0.42$463.90 million$471.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415$1.27$1.68$570.80 million$570.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$0.54$0.59$495.55 million$469.96 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215$0.78$0.97$494.85 million$506.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115$0.33$0.61$474.60 million$472.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$1.18$1.34$593.41 million$598.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314$0.86$0.39$525.40 million$530.64 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.95$1.09$537.58 million$536.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.80$0.23$515.00 million$509.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413$1.42$1.04$586.67 million$602.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313$0.91($0.25)$529.02 million$505.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$1.25$1.20$532.60 million$525.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013$1.03$0.68$506.34 million$499.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$1.33$1.65$558.68 million$573.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312$1.14$1.48$507.79 million$498.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$1.19$1.69ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$1.02$1.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$1.67$2.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$1.53$1.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$1.47$1.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$1.32$1.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$1.35$2.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Rad Laboratories (NYSE:BIO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.72$0.85$0.79
Q2 20163$1.01$1.12$1.07
Q3 20162$0.84$0.92$0.88
Q4 20163$1.09$1.55$1.25
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bio-Rad Laboratories (NYSE:BIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio-Rad Laboratories (NYSE:BIO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Bio-Rad Laboratories (NYSE:BIO)
DateHeadline
07/29/16 06:40 AMExpected For Bio-Rad Laboratories, Inc. (NYSE:BIO) Sales Of $2088.8 - Investor Newswire
07/28/16 11:36 AMNucleic Acid Testing Market Growth, Trends and Value Chain 2015-2025 by FMI
07/28/16 11:36 AMGlobal biochips market 2015 is estimated to grow USD 25.8 billion by 2022
07/28/16 11:36 AMViral Molecular Diagnostics Market : Potential and Niche Segments, Geographical regions and Trends to 2020
07/27/16 08:36 PMMicrobiology Testing Technologies Market to be Driven by Rising Incidences of Infectious Diseases Globally
07/27/16 11:20 AMFlow cytometry market is projected to reach 4.93 billion USD by 2021 according to market forecasts
07/27/16 11:20 AMGlobal Biodetectors and Accessories Market 2015 Analysis and Forecast to 2022
07/27/16 11:20 AMHigher Incidence of Cancers and Chronic Diseases to Boost Molecular Diagnostics Market to USD 9.5 Billion by 2020 - iHealthcareAnalyst, Inc.
07/27/16 11:20 AMGlobal Polymerase Chain Reaction (PCR) Technologies Market 2015
07/27/16 07:06 AMBio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : BIO-US : July 27, 2016 -
07/26/16 10:26 AMGlobal alcohol breathalyzer and drug testing equipment market 2015 is estimated to grow at a CAGR of 8.1% during 2015 to 2022
07/26/16 10:26 AMBiomarkers Market : Dynamics, Segments, Size and Demand to 2014 – 2020
07/25/16 08:55 PMBiochips Market : Opportunities and Forecasts, 2014 – 2020
07/25/16 08:55 PMHigher Incidence of Cancers and Chronic Diseases to Boost Molecular Diagnostics Market to USD 9.5 Billion by 2020
07/25/16 08:55 PMGlobal In Vitro Diagnostics Market 2016 Share, Trend, Segmentation and Forecast to 2022
07/25/16 03:21 PMNew Broker Ratings For Bio-Rad Laboratories, Inc. (NYSE:BIO ... - FTSE News
07/24/16 07:33 AMPolymerase Chain Reaction (PCR) Technologies Global Market Expected to Grow at 8.8% by 2022
07/24/16 07:33 AMWorldwide Label-Free Detection Systems Market : Information, Figures and Analytical Insights 2020, PMR report
07/23/16 02:47 PMStock Performance Rundown on Bio-Rad Laboratories, Inc. (NYSE:BIO) - Engelwood Daily
07/23/16 07:04 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Current Analyst Ratings - Fiscal Standard
07/23/16 07:04 AMFriday Session Wrap-up for Bio-Rad Laboratories, Inc. (NYSE:BIO) - Engelwood Daily
07/22/16 11:02 AMLife Science Market : Latest Innovations, Drivers and Industry Key Events 2016 – 2022
07/21/16 02:53 PMHigh Expectations Remain For Bio-Rad Laboratories, Inc. (NYSE:BIO) - TGP
07/21/16 11:20 AMImmunoassay Market Segmentation,Parameters and Prospects 2016 to 2022 Market Research Report
07/21/16 11:20 AMGlobal Bioinformatics Market 2016 Research, Clinical Analysis, Trends, Production, Price, Consumption, Revenue 2025
07/20/16 09:44 PMAcadian Asset Management LLC Marginally Increases Its Investment in Bio-Rad Laboratories, Inc. Clas (BIO) - Finance Daily
07/20/16 03:20 PMMolecular Diagnostics Market Analysis By Product (Instruments, Reagents), By Test Location (Point of …
07/20/16 10:53 AMFlow Cytometry Market Worth 4.93 Billion USD by 2021
07/20/16 10:53 AMBio-Rad Launches ddPCR™ CHO and E. coli Kits for Direct Quantification of Residual Host Cell DNA
07/19/16 08:13 PMCell Counting Market by Product, End User and Geography from 2016 to 2024
07/19/16 02:51 PMStock Positive on the Year: Bio-Rad Laboratories, Inc. (NYSE:BIO) - TGP
07/19/16 02:51 PMSolid Performer in Focus: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Engelwood Daily
07/19/16 09:01 AMGlobal High-performance Liquid Chromatography Systems Market Analysis 2016 and Forecast to 2021
07/19/16 09:01 AMGlobal urinalysis market size & share 2022 illuminated by new report
07/18/16 02:54 PMImmunoassay Market Size, Analysis, Trends, Report, Share, Investment Opportunities and Forecast to 2022
07/18/16 02:54 PMAutoimmune Disease Diagnostics Market to Expand at 3.80% CAGR 2015-2023, Driven by Growing Awareness Among Patients
07/18/16 07:47 AMBlood Testing Market Size Is Projected To Reach USD 62.9 Billion By 2024: Grand View Research, Inc.
07/18/16 07:47 AMAutomated Molecular Diagnostics Testing System Market Growth, Trends, Absolute Opportunity and Value Chain 2016-2026
07/17/16 07:33 AMShare Performance Summary for: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Press Telegraph
07/16/16 08:14 AMAnalysts Are Expecting this Stock to Rise: Bio-Rad Laboratories, Inc. (NYSE:BIO) - TGP
07/16/16 08:14 AMBuy or Hold? What are Analysts Saying About Bio-Rad Laboratories, Inc. (NYSE:BIO) - Telanagana Press
07/15/16 07:05 PMIn Vitro Diagnostics Market Size, Analysis, Report, Trends, Share, Opportunities and Forecast To 2022
07/15/16 07:05 PMFlow Cytometry Market 2016: Industry Demand, Insight, Profile and Research to 2020
07/15/16 01:24 PMInstitutions are Decreasing Positions in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Telanagana Press
07/15/16 01:24 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Yearly Sales Target At $2087.9 - Investor Newswire
07/15/16 01:24 PMNew Broker Ratings For Bio-Rad Laboratories, Inc. (NYSE:BIO) - FTSE News
07/14/16 08:18 PMBio-Rad Launches ddPCR™ CHO and E. coli Kits
07/14/16 11:43 AMProteomics Market to Increase at Steady Growth Rate
07/13/16 02:49 PMStocks Hurt By Unusual Move- Microsoft Corporation (NASDAQ:MSFT), Bio-Rad Laboratories (NYSE:BIO), Gildan ... - Seneca Globe
07/13/16 10:55 AMTransfection Technology Market Detailed Analysis with Forecast by 2019

Social

About Bio-Rad Laboratories

Bio-Rad Laboratories logoBio-Rad Laboratories, Inc. (Bio-Rad) manufactures and supplies products and systems used for the life science research, healthcare, analytical chemistry and other markets. The Company offers products to separate complex chemical and biological materials, and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments. The Company's Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and quality controls that serve clinical laboratories in the global diagnostics market. Bio-Rad's product brands include Droplet Digital and BioPlex. As of December 31, 2014, the Company had direct distribution channels in over 35 countries outside the United States through subsidiaries.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: BIO
  • CUSIP: 09057220
Key Metrics:
  • Previous Close: $145.09
  • 50 Day Moving Average: $142.93
  • 200 Day Moving Average: $138.24
  • P/E Ratio: 39.67
  • P/E Growth: 4.21
  • Market Cap: $4.27B
  • Beta: 0.99
  • Current Year EPS Consensus Estimate: $3.4 EPS
  • Next Year EPS Consensus Estimate: $4 EPS
Additional Links:
Bio-Rad Laboratories (NYSE:BIO) Chart for Saturday, July, 30, 2016